Results 91 to 100 of about 2,196,135 (231)

Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas : A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study) [PDF]

, 2019
Background and Aims: Stenosis due to intimal hyperplasia and restenosis after initially successful percutaneous angioplasty are common reasons for failing arteriovenous fistulas. The aim of this study was to evaluate the effect of drug-coated balloons in
Venermo, M., Weselius, E. -M., Kokkonen, T., Rauta, V., Björkman, P., Alback, A.   +5 more
core   +1 more source

Intravascular lithotripsy for recurrent calcific in-stent renal artery stenosis in a functionally solitary kidney: Two-year hemodynamic durability

Annals of Vascular Surgery - Brief Reports and Innovations
Purpose: To illustrate a case of renal artery in-stent restenosis successfully treated with shockwave lithotripsy. Methods: This is a case report of a patient with solitary kidney and renal artery in-stent stenosis treated with percutaneous lithotripsy ...
C. Shirley, J. Campbell, M. Moursi, O. Gudz   +3 more
doaj   +1 more source

Calcified Plaque Detachment: Alternative Calcified Plaque Modification After Coronary Intravascular Lithotripsy

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Calcified plaque (CP) detachment (CD) and calcium fracture (CF) can occur following coronary intravascular lithotripsy (IVL). The extent to which CF alone facilitates stent expansion during CP modification with IVL remains unclear. Aims This study aimed to investigate the clinical implications of IVL‐induced CD.
Daisuke Naito, Akiko Matsuo, Takeru Kasahara, Keisuke Ota, Shinsaku Matsunaga, Norio Nakajima   +5 more
wiley   +1 more source

Final 2‐Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In‐Stent Restenosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In the REFORM trial, treatment of coronary in‐stent restenosis with a Biolimus A9™ drug‐coated balloon (BCB) was found to be inferior with respect to in‐segment percentage stenosis at 6‐months in comparison to treatment with a standard paclitaxel coated paclitaxel‐coated balloon (PCB). Aims In this manuscript, the final prespecified
Daniel O'Callaghan, J. J. Coughlan, Fernando Alfonso, Joo‐Yong Hahn, Manel Sabate, Ralph Toelg, Samuel Copt, Sean Fitzgerald, Marie‐Claude Morice, Jasper Trevelyan, Darren Mylotte, Antonio Fernandez Ortiz, Rory Durand, Jochen Wöhrle, Franz Xever Kleber, Giuilo Stefanini, Himanshu Rai, Peter O'Kane, Robert A. Byrne   +18 more
wiley   +1 more source

Buddy Wire–Augmented Intravascular Lithotripsy in Refractory Calcified Coronary Lesions: A Five‐Case Series

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Heavily calcified coronary lesions remain a major challenge in percutaneous coronary intervention (PCI), often limiting the effectiveness of intravascular lithotripsy (IVL). We report a five‐case series in which IVL failed to achieve adequate lesion modification but was successfully augmented by the addition of one or more buddy wires.
Alfredo Marchese, Mattia Squillace, Pierluigi Demola, Giuseppe Speziale, Francesco Bedogni, Robert J. Chilton   +5 more
wiley   +1 more source

Clinical outcomes of drug-coated balloon angioplasty for venous in-stent restenosis: A prospective clinical study

Pakistan Journal of Pharmaceutical Sciences
Background: In-stent restenosis (ISR) is still a significant barrier in achieving long-term benefits from venous stent placement for patients suffering from iliofemoral deep vein thrombosis (IFDVT).
Orhan Rodoplu
doaj   +1 more source

Evaluating the Clinical Outcomes of Drug-Coated Balloon and Conventional Balloon Angioplasty in the Management of Stent Edge Restenosis

Allied Medical Research Journal, 2023
Background Coronary stenting is frequently complicated by stent edge restenosis (SER), which causes the artery to re-narrow. Drug-eluting stents (DES), plain balloon angioplasty (POBA), conventional balloon angioplasty (CBA), and drug-coated balloons (
Dr. Nasir Khan, Dr. Usman Iqbal, Dr. Muhammad Wajahat Jan, Dr. Rahman Ullah   +3 more
doaj  

Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In small, tortuous coronary lesions, the long‐term comparative performance of drug‐coated balloon (DCB) angioplasty versus drug‐eluting stent (DES) treatment remains uncertain, despite both strategies being widely used in contemporary percutaneous coronary intervention (PCI) practice. Aims This study aimed to compare 3‐year clinical
Shunichiro Ishio, Takashi Nagasaka, Ryota Taniuchi, Shiro Amanai, Yohei Ishibashi, Noriaki Takama, Hideki Ishii   +6 more
wiley   +1 more source

Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.

JACC: Cardiovascular Interventions
BACKGROUND Whether intraluminal drug-coated balloon (DCB) angioplasty is superior to subintimal DCB angioplasty regarding femoropopliteal (FP) chronic total occlusion (CTO) outcomes has not been systematically determined.
T. Toyoshima, M. Takahara, Osamu Iida, Y. Tomoi, D. Kawasaki, A. Tanaka, Yasutaka Yamauchi, K. Tobita, A. Kozuki, M. Fujihara, Y. Higuchi, Y. Soga   +11 more
semanticscholar   +1 more source

A Large Retrospective Study to Evaluate Utility of Zephyr Covered Stent in Transcatheter Closure of Sinus Venosus Defects

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter closure (TCC) of sinus venosus defects (SVD) using balloon‐expandable covered stents is an emerging alternative to surgery. ZephyrCS (Sahajanand Laser Technologies, Gandhinagar, India) is available in long lengths to suit SVD closure.
Pramod Sagar, Puthiyedath Thejaswi, Kothandam Sivakumar, Praveen Ashok Kumar   +3 more
wiley   +1 more source